Seniors are most likely to report using cannabis products to address symptoms of anxiety, chronic pain, depression, glaucoma, and HIV/AIDS.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Tax revenues derived from the licensed retail sale of state-legal, adult-use cannabis products grew by more than 30 percent between 2020 and 2021.
Investigators concluded that medical cannabis can “safely and significantly lower the consumption of co-medicated opioids, even at low dosages.”
Fifty-two percent of American adults have tried marijuana during their lifetimes, including 63 percent of those between the ages of 45 and 64.
Researchers concluded, “Placements due to physical abuse, parental neglect, and parental incarceration decrease after legalization, providing evidence that legalization reduces substantive threats to child welfare.”
Consistent with prior studies, most respondents (76 percent) said that they had received no “formal training regarding medical cannabis.”
For decades, scientists have complained that federally provided cannabis is of inferior quality and that it is not representative of the products available in state-legal markets.
Investigators concluded, “[O]ur findings failed to find evidence that legalization of commercial marijuana was associated with any significant change in entry into marijuana‐related treatment services.”
